Prevalence of hepatitis G virus infection in kidney transplant recipients

Transplantation. 1997 Aug 15;64(3):537-9. doi: 10.1097/00007890-199708150-00029.

Abstract

Background: We investigated the prevalence, risk factors, and consequences of hepatitis G virus (HGV) infection in 87 kidney transplant recipients.

Methods: Infection was diagnosed with reverse transcriptase polymerase chain reaction using primers in the NS3 region of the viral genoma.

Results: Twenty-four patients (27.5%) were HGV RNA positive (HGV+ group) and 63 patients (72.5%) were HGV RNA negative (HGV- group). No statistically significant differences were found between the two groups for age, sex, transplantation and hemodialysis duration, number of kidney transplantations, serum creatinine, history of transfusions, hepatitis B and C virus infections, and percentage of patients having suffered from acute rejection. Acute and chronic hepatitis were not more prevalent in the HGV+ group than in the HGV- group.

Conclusions: HGV infection is highly prevalent in kidney transplant recipients but does not alter liver or kidney functions. HGV contamination may be linked to nosocomial transmission during long-term hemodialysis.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Alanine Transaminase / blood
  • Aspartate Aminotransferases / blood
  • Female
  • Flaviviridae* / genetics
  • Hepatitis, Viral, Human / blood
  • Hepatitis, Viral, Human / complications
  • Hepatitis, Viral, Human / epidemiology*
  • Humans
  • Kidney Transplantation / adverse effects*
  • Kidney Transplantation / statistics & numerical data
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Prevalence
  • Prospective Studies
  • RNA, Viral / blood
  • Risk Factors

Substances

  • RNA, Viral
  • Aspartate Aminotransferases
  • Alanine Transaminase

Associated data

  • GENBANK/U44402